A B S T R A C T Captopril, 5 mg/kg, administered to pregnant rabbits caused a reduction in mean arterial pressure (MAP) from 106±2 to 87±2 mmHg (P < 0.01) without change in cardiac output or renal blood flow.
INTRODUCTION
During human pregnancy, there is an increase in plasma concentration of renin, angiotensin II (All),' prostaglandin E2 (PGE2), and prostacyclin (PGI2) (1) (2) (3) . The source of these vasoactive substances is not clear; the elevated plasma renin seems in part of renal origin since in pregnant animals and women, it responds to changes in sodium intake (4, 5) . The high plasma PGE2 is associated with elevated urinary PGE2 excretion, a reflection of increased renal synthesis (6) , so the kidneys may be a source of the elevated plasma PGE2. However, the uterus of pregnant animals (7) and women (8) contains high concentration of renin and high concentrations of PGE2 and PGI2 have been reported in the uterine vein of pregnant animals (2, 9) . Whether increased uterine synthesis of these compounds contributes to the elevated plasma concentration seen in human pregnancy is unclear. Renin and PGE2 may function locally in the uterus as regulators of blood flow; inhibitors of prostaglandin synthesis are known to reduce uterine blood flow in pregnant animals (2) and All increases uterine blood flow in the pregnant rabbit (10) , dog (11) , and monkey (12) . The increase in uterine blood flow with All may be caused by uterine prostaglandin synthesis, since All increases PGE2 synthesis in the uterus (13) , and the increase in uterine blood flow is blocked by indomethacin.
In addition to prostaglandins potentially playing a role in control of uterine blood flow, the increase in plasma PGE2 and PGI2 might be the cause of the insensitivity to All that occurs throughout pregnancy (14) . Elevated All may be required in pregnancy to overcome antagonism caused by increased synthesis of vasodilating prostaglandins. Saralasin, an angiotensin antagonist, significantly reduces arterial pressure in pregnant rabbits (15) , and the decreased All responsiveness in pregnant women is reversed with indomethacin (16) .
To further examine the interrelationship of uterine All and PGE2 synthesis during pregnancy, we administered the angiotensin I-converting enzyme, Captopril, acutely and chronically, to pregnant rabbits. Our results demonstrate that uterine synthesis of PGE is dependent on All and that synthesis of uterine All and PGE is vital for maintenance of uteroplacental blood flow and fetal survival.
METHODS
Acute studies. Pregnant rabbits were studied on approximately the 26th d of pregnancy. Animals were anesthetized with sodium pentobarbital, 30 uterine, and placental blood flow. The digestion of the placenta and attached segment of uterus was considered placental blood flow whereas the uterus not underlying placenta was termed uterine blood flow; the combined flows were total uterine blood flow. The digested organ material was then placed in a scintillation vial and counted for the specific isotopes used (gamma 2000, Beckman Instruments, Inc., Fullerton, CA). Organ blood flows were calculated as previously described (17) .
Plasma renin activity (PRA) was measured by radioimmunoassay by the method of Haber et al. (18) after incubation for 3 h at ph 5.7. Plasma PGE was measured by immunoassay (19) . All samples from one animal were assayed at the same time to avoid interassay variation. The intraassay CV was 4%. The lower limit of sensitivity of this assay is 50 pg/ml. Recovery Table I demonstrates the hemodynamic data obtained before and after the acute administration of Captopril, 5 mg/kg, i.v., in eight pregnant and six nonpregnant rabbits. MAP fell significantly in the pregnant rabbits (P < 0.01) whereas there was no significant change in MAP in the nonpregnant animals. Cardiac output and renal blood flow did not change significantly after Captopril in either group of animals. Total uterine blood flow fell after Captopril, 31.9±2.2 to 21.3±3.4 ml/min, (P < 0.01), with placental blood flow falling from 21 .2±1.8 to 9.5±1.8 ml/min, (P < 0.01), Fig. 1 Significantly higher PRA was found in the uterine vein than peripheral vein in the control period 11.0±3.0 ng/ml per h compared with 6.0±1.6 ng/ml per h, (P < 0.05) and there was a striking increase in uterine vein renin concentration after Captopril to 90.0±19.0 ng/ml per h (P < 0.01), with peripheral venous PRA rising to 62.0±19.0 ng/ml per h, (P <0.05). Thus, uterine renin secretion into the circulation occurred before and after Al blockade (Fig. 2) .
After Captopril there was a fall in uterine vein PGE concentration from 127±23 ng/ml to 26±8 ng/ml (P < 0.01), (Fig. 3) . This was not associated with change in peripheral venous PGE that was 1.13±0.06 ng/ml before and 1.12±0.05 ng/ml after Captopril. No significant change in uterine vein PGE occurred with MgSO4; 80±22 ng/ml before and 60±27 ng/ml after MgSO4.
In six other pregnant rabbits renal venous PGE was determined and found to be 3.0±0.3 ng/ml before and If one roughly compares the secretion rate of uterine and renal PGE, the uterus appears to be a far more significant source of this prostaglandin in the pregnant rabbit. In the control period uterine PGE secretion was -3,800 ng/min, which fell to 520 ng/min after Captopril. Renal PGE secretion remained -240 ng/min before and after Captopril. Thus, the failure to demonstrate an effect on plasma PGE after Captopril is difficult to explain. Donker and Venuto (23) found that Captopril increased plasma PGE2 in nonpregnant rabbits from 0.36±0.21 to 0.92±0.56 ng/ml (P < 0.01), whereas it fell in pregnant animals from 1.06±0.23 to 0.81±0.16 ng/ml (P < 0.025). Since the uterine circulation contributes such a large quantity of PGE2 into the circulation in the pregnant rabbit with only modest increase in peripheral PGE2 concentration the metabolism of PGE2, particularly in the pulmonary vasculature may increase in pregnancy. Measurements of PGE2 metabolites would be of interest in pregnancy.
Previous studies have demonstrated that indomethacin reduces uterine blood flow and uterine vein PGE concentration in anesthetized pregnant rabbits (2) and the effect of Captopril reemphasizes the dependency of uterine blood flow on prostaglandin synthesis. The fall in uteroplacental blood flow would appear to be secondary to reduced uterine prostaglandin synthesis rather than reduction in perfusion pressure since MgSO4 failed to reduce uterine blood flow in spite of greater reduction in blood pressure. Previous studies have demonstrated that uterine blood flow in the pregnant rabbit autoregulates flow over a range of mean perfusion pressure from '60 to 140 mmHg (24) .
These studies with Captopril and saralasin also demonstrate that arterial pressure in the pregnant rabbit is dependent upon high levels of circulating All. Although our studies were done in anaesthetized animals others have reported a similar reduction in pregnant unanaesthetized rabbits following saralasin and Captopril (15) (23). Thus, PGE2 and All synthesis during pregnancy may be of importance not only in the control of uteroplacental blood flow but also in maintenance of arterial pressure.
Pregnancy is unlike the nonpregnant state where the concentration of plasma renin and All can be accounted for on the basis of changes in extracellular volume or sodium balance. Normally, as extracellular volume expands there is an increase in renal perfusion pressure, increased delivery of filtered sodium to the distal tubule and diminished renal sympathetic nerve activity, all of which cause renal renin secretion to fall. During pregnancy, high secretion of renin occurs during expansion of the extracellular volume, increased renal blood flow and glomerular filtration rate and presumably increased delivery of sodium to the macula densa. Persistent secretion of renin and aldosterone occurs in human pregnancy inspite of a high sodium intake (5). This nonsuppressible secretion of renin during volume expansion may be caused by renal prostaglandin synthesis. Prostaglandin synthesis, probably in the juxtaglomerular apparatus, is known to be of importance in control of renin secretion. Cycloxygenase inhibition lowers renal renin secretion and sodium arachidonate, the precursor of prostaglandin synthesis, increases renin secretion both from the kidney and renal cortical slices (25) . Pregnancy is similar to Bartter's syndrome where persistent renin secretion occurs during volume expansion. The insensitivity of the vasculature to All in pregnancy is also similar to Bartter's syndrome where increased plasma PGE2 and PGI2 have also been demonstrated (26) .
Since blood pressure was not lowered during chronic administration of Captopril, some adaptation must have occurred. We did not measure plasma or urinary PGE during chronic Captopril administration but a reduction in prostaglandin synthesis might decrease the need of high levels of All to maintain arterial pressure. One problem in interpreting urinary or plasma PGE2 concentration with chronic Captopril administration would be determining when fetal death occurred since plasma PGE might fall on that basis. In most of the chronically treated animals we studied, the fetuses were found dead in utero at the time of sacrifice but blood pressure was normal also in animals that had viable fetuses at the time of killing. Thus, we do not feel the failure to see hypotension with chronic Captopril was due to fetal death in all instances.
Conceivably, the component of renin secretion not suppressed by a high salt diet in pregnant women is of uterine origin. High concentration of renin in the uterus of animals and humans has been demonstrated in several studies over the past 20 yr (7, 8) but its potential role in the elevated plasma renin of pregnancy has not been clarified. Uterine renin is released into the circulation during reduction in uterine perfusion (10) or following nephrectomy (7) and in the present experiments uterine venous renin was always higher than peripheral PRA. The increase in uterine renin secretion with Captopril is similar to what occurs in the kidney and suggests that uterine renin release is effected by All concentration. The uterus may have a "short loop" feedback system where All inhibits renin release (27) and the uterus, like the kidney, probably possesses the dipeptidyl carboxypeptidase which converts Al to All. Although this enzyme is located primarily in pulmonary vascular endothelial cells, there is evidence that it exists in all vascular beds (20) .
Captopril increases renal blood flow in rabbits when a high plasma renin has been induced by a low salt diet whereas, on a normal sodium intake no increase in renal blood flow or glomerular filtration rate occurs (28) . Similarly, in the conscious dog intrarenal infusion of Captopril increases renal blood flow only when the dog is on a low sodium intake (29) . It is interesting that activation of the renin angiotensin system with pregnancy is not similar to a low salt intake since no increase in renal blood flow occurs with Captopril women treated with antihypertensive drugs are similar to untreated pregnant hypertensives and there is no evidence of altered fetal growth. The findings we report with Captopril would make it contraindicated in human pregnancy. It is intriguing to speculate that a possible imbalance in the synthesis of renin and prostaglandin might be a factor in the abnormalities seen in toxemia of pregnancy. The uterine hypoperfusion and the higher fetal mortality present in toxemia, might be due to reduced uterine All or PGE synthesis. Increased sensitivity to All occurs with toxemia, which may also reflect a decrease in synthesis of a vasodilating prostaglandin of either uterine or vascular origin. The effect of aspirin, a prostaglandin-inhibiting drug, on pregnancy has been reported in two studies. In one study (32) , a high infant mortality and low birth weight was reported, which was not confirmed in another study (33) .
In conclusion, uterine blood flow in the pregnant rabbit is dependent upon synthesis of PGE and All. When All synthesis is blocked there is a fall in uterine PGE synthesis, a decline in uteroplacental blood flow and a striking rise in fetal mortality. In addition to the effects of All in controlling uterine blood flow and arterial pressure in pregnancy, fetal survival is also dependent on formation of All. These findings demonstrate an intimate relationship between uterine production of renin, All and prostaglandins during pregnancy.
